• BX Home
  • Pharmaceutical Approvals: Blog

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PHARMACEUTICAL APPROVALS

Pharmaceuticals approvals are the last step in a long process of government testing. This topic tracks the approval of prescription and over-the-counter pharmaceuticals.

Pharmaceutical Approvals is part of Business Exchange, suggested by Evan Rappaport. This topic contains 1,734 news and 206 blog items. Read updated news, blogs, and resources about Pharmaceutical Approvals. Find user-submitted articles and reactions on Pharmaceutical Approvals from like-minded professionals.

Blogs

Recent blog posts on this topic.

The NIH's Drug Repurposing Initiative: Will It Be a Waste?more

The NIH's attempt to repurpose shelved development compounds and other older drugs is underway: The National Institutes...

A New Way to Kill Amoebas, From An Old Drugmore

Here's a good example of phenotypic screening coming through with something interesting and worthwhile: they screened...

A New Way to Kill Amoebas, From An Old Drugmore

Here's a good example of phenotypic screening coming through with something interesting and worthwhile: they screened...

Arena and Lorcaserin, Back at the FDAmore

For those of you following Arena Pharmaceuticals and their long-running efforts to get lorcaserin approved by the FDA,...

Benlysta's Advertures In the Real Worldmore

Benlysta got approved for lupus last year, as the first new drug in the field in decades. But as noted at the time, it...

The Biotech Class of the Early 90smore

Here's an excellent piece by venture capital guy Bruce Booth, looking back at the heady days of 1991-1994.

The Biotech Class of the Early 90smore

Here's an excellent piece by venture capital guy Bruce Booth, looking back at the heady days of 1991-1994.

Regulatory Hurdlesmore

John LaMattina has a good piece up on the FDA, where they might be trying to have it both ways. About a recent speech...

Regulatory Hurdlesmore

John LaMattina has a good piece up on the FDA, where they might be trying to have it both ways. About a recent speech...

India's First Drug Isn't India's First Drugmore

There have been a number of headlines the last few days about Ranbaxy's Synriam, an antimalarial that's being touted as...

India's First Drug Isn't India's First Drugmore

There have been a number of headlines the last few days about Ranbaxy's Synriam, an antimalarial that's being touted as...

How Do Drugs Get Into Cells? A Viscious Debate.more

So how do drug molecules (and others) get into cells, anyway? There are two broad answers: they just sort of slide in...

How Do Drugs Get Into Cells? A Viscious Debate.more

So how do drug molecules (and others) get into cells, anyway? There are two broad answers: they just sort of slide in...

AstraZeneca Buys Ardea. And Who Else?more

Since I've mentioned Ardea Pharmaceuticals and their gout drug RDEA594 (lesinurad) here a couple of times, I should...

Making Their Own ALS Drugmore

We should expect to see more of this sort of thing. The Wall Street Journal headline says it all: "Frustrated ALS...

Making Their Own ALS Drugmore

We should expect to see more of this sort of thing. The Wall Street Journal headline says it all: "Frustrated ALS...

Europe Wants Some of That Molecular Library Actionmore

We've talked about the NIH's Molecular Libraries Initiative here a few times, mostly in the context of whether it...

Pfizer: Making the Case for a Breakupmore

I would not like to count the number of times I've said bad things here about pharma mergers. The best of them, as far...

Nativis Updatemore

Longtime readers will remember the interaction I had with Nativis Pharmaceuticals. That's the outfit that claims to be...

Merck's CALIBR Venturemore

So the news is that Merck is now going to start its own nonprofit drug research institute in San Diego: CALIBR, the...

Not Quite So Accelerated, Says PhRMAmore

We've spent a lot of time here talking about provisional approval of drugs, most specifically Avastin (when its...

Targets to Avoid (Or That We Wish We Had)more

A discussion with colleagues recently got me to wondering about this useful (albeit grim) question: what area of drug...

Targets to Avoid (Or That We Wish We Had)more

A discussion with colleagues recently got me to wondering about this useful (albeit grim) question: what area of drug...

Terra Slightly Less Incognitamore

Back last year I did a brief post about how much not-so-exotic druglike chemical matter has never been explored.

China's Home-Grown Insanity?more

Can this possibly be accurate? There are photos going around of what is purported to be the inside of the Harbin Sixth...

Top Sources: Pharmaceutical Approvals

  • SeekingAlpha.com: Home Page
  • DODTracker.com New Deals Feed
  • stockerblog.blogspot.com
  • What's New at CBER
  • RSS from PharmiWeb.com
  • futurebiopharma.blogspot.com
  • FDA Law Blog
  • In the Pipeline
  • Health News from Medical News Today
  • Medical Device Recalls since November 11, 2009

Most Active Users in this Topic

see all contributors in Pharmaceutical Approvals

Featured White Papers

Post a Job

Jobs in this Topic

Director Quality Assurance - Drug Delivery Devices Job Merck | West Point, PA
Posted: May 8
Pharmaceutical Tech - Level 1 (Continuous Recruitment) Job Merck | West Point, PA
Posted: Apr 30
Specialty Pharmaceutical Sales Fortune 500 | Indianapolis, IN
Posted: May 21
Fda Compliance Specialist - Southwest Region Airgas | Houston, TX
Posted: May 9
Director, Global Pharmacovigilance/Drug Safety Clinical Dynamix | Missouri
Posted: Apr 24

Report comment contains invalid characters. ()
cancel
Search Cancel